NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Volta Labs

Volta Labs

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://voltalabs.com/

Last Round

Series A

Extension

Mar 22, 2024

Est. Valuation

$92.7M

Total Funding Raised

$37.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Volta Labs is a biotechnology company that provides a biological automation and genomic sample preparation platform designed to streamline complex workflows in genomics research through innovative automation and miniaturization techniques.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

digital fluidicsgenomic sample preparationnext-generation sequencingNGSlab automationlibrary preparationbenchtop sequencerautomated liquid handlinggenomics workflowbiotech hardwaresequencing consumableshigh-throughput sequencingwet lab automationmolecular biology toolslab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Volta Labs Comparables

Compare Volta Labs with similar companies based on industry and business-model similarity.

Volta Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
INTEGRA Holding AG
83%
Danaher Corporation
78%
Tecan Group Ltd.
76%

Volta Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 22, 2024
Seed RoundJan 12, 2024
Series AMar 17, 2022
SeedMar 18, 2019

Key People

Founding team and executive leadership

Udayan Umapathi

Founder And CEO

Founding Team

Volta Labs Investors

Notable investors and investment history

Volta Labs investors
InvestorRounds
Blindspot VenturesSeries A
Maverick VenturesSeries A, Seed
FundomoSeries A Extension
Khosla VenturesSeries A
Blindspot VenturesSeries A
Y CombinatorSeed
Casdin CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 26, 2026

    Collaborating with Watchmaker Genomics to enhance Callisto platform.

  • Feb 26, 2026

    Collaborating with Roche to expand Callisto sequencing platform capabilities.

Volta Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Volta Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Volta Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range53
Year Founded2018
Last FundingMar 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.